| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Dec―18 |
SAFETY OF COMMONLY USED OVER-THE-COUNTER DRUGS IN SELF-MEDICATION FOR COVID-19 |
|
| 2 |
[GO] |
2023―Dec―18 |
Cognitive impairment as a result of the direct impact of COVID-19 on the nervous system |
M. M. Oros |
| 3 |
[GO] |
2023―Jan―20 |
Comparison of IgG concentrations to SARS-CoV-2 virus, their correlation with lymphocyte activation markers CD25, CD54 (ICAM-1) and CD95 in patients with COVID-19 and with seasonal viral diseases. Possibilities of correcting a disturbed immune response wit |
L. M. Velichko, S. M. Gusev, A. V. Bogdanova, N. V. Konovalova, N. I. Khramenko, M. B. Makarova, A. L. Molodaya, M. I. Borisova, Yu. V. Kozorez, M. A. Kalinichenko |
| 4 |
[GO] |
2022―Sep―26 |
Liver injury in COVID-19 |
T. M. Bentsa |
| 5 |
[GO] |
2022―Sep―26 |
Efficacy of the drug Mercurid in the treatment of complications of COVID-19 |
L. S. Babinets, L. M. Velichko, N. V. Konovalova |
| 6 |
[GO] |
2022―Sep―26 |
Pharmacotherapy of cognitive dysfunction after the postponed COVID-19: drug selection criteria |
S. G. Burchinsky, N. Yu. Bachynska |
| 7 |
[GO] |
2021―Sep―13 |
COVID-19 and heart |
V. Y. Tseluyko |
| 8 |
[GO] |
2021―Sep―13 |
Clinical case of musculoskeletal system disorder in patients with COVID-19 |
L. V. Zhuravlyova, V. O. Fedorov, M. O. Oliinyk, J. K. Sikalo, N. V. Erakhtorina, T. I. Khovrat |
| 9 |
[GO] |
2020―Dec―30 |
A new problem: diabetes mellitus and COVID-19 |
L. V. Zhuravlyova, O. V. Ogneva |
| 10 |
[GO] |
2020―Dec―29 |
ORDER «ON AMENDMENTS TO THE STANDARDS OF MEDICAL CARE «CORONAVIRUS DISEASE (COVID-19)» (SELECTED GUIDELINES) |
D. Motruk |
| 11 |
[GO] |
2020―Dec―29 |
NEW CASES OF COVID-19 EXPAND THE CAPABILITIES OF HEALTH CARE INSTITUTIONS |
D. Motruk |
| 12 |
[GO] |
2020―Dec―28 |
THE STATE FOOD AND CONSUMER SERVICE HAS PUBLISHED ANSWERS TO THE MOST FREQUENT QUESTIONS ABOUT COVID-19 |
D. Motruk |
| 13 |
[GO] |
2020―Dec―28 |
A new problem: diabetes mellitus and COVID-19 |
L. V. Zhuravlyova, O. V. Ogneva |
| 14 |
[GO] |
2020―Dec―28 |
PROTOCOL: «PROVISION OF MEDICAL CARE FOR THE TREARMENT OF CORONAVIRUS DISEASE (COVID-19)» |
D. Motruk |
| 15 |
[GO] |
2020―Dec―28 |
Is spironolactone effective in preventing atypical pneumonia caused by COVID-19 in patients with hypertension? |
V. Yе. Sabadash, O. О. Alifer, E. N. Zakharets |
| 16 |
[GO] |
2020―Dec―28 |
NON-REGISTERED MEDICINES FOR COVID-19 TREATMENT: THE RELEVANT LAW HAS COME INTO FORCE |
D. Motruk |
| 17 |
[GO] |
2020―Dec―28 |
NEW CHANGES FROM AND TO STANDARDS IN THE FIGHT AGAINST CORONAVIRUS DISEASE |
D. Motruk |
